Acute Heart Failure Monitoring Via Inferior Vena Cava Ultrasound

Completed

• Conditions: Chronic Heart Failure

• Registration Number: NCT02725151
• Lead Sponsor: Haseki Training and Research Hospital

Brief Summary

Known before diagnosed heart failure and used diuretic therapy patients will be admitted in this study.The objective of this work is whether the Inferior Vena Cava Ultrasound can be used for management of Acute Heart failure therapy. And investigators will calculation correlation of extracted urine amount with Inferior Vena Cava diameter change. Researchers will not interfere to standard recommended treatment protocol, researchers will correlated the urine amount and changed vital signs with therapy with Vena cava inferior diameter.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-08
• Study First Submitted: 2016-03-20
• Study First Submitted QC: 2016-03-30
• Study First Posted: 2016-03-31
• Primary Completion: 2016-08
• Study Completion: 2017-01
• Status Verified: 2021-02
• Last Update Submitted: 2021-02-28
• Last Update Posted: 2021-03-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• Adult patients (> 18 years of age) of both sexes)
• Non-trauma patients
• Non- pregnant patients
• All patients will be accepted for this study, that known Heart Failure and must be taken diuretic therapy because of volume overload

Exclusion Criteria

• Cardiac tamponade
• Aortic dissection
• Patients who had suffered cardiopulmonary arrest or been intubated

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vena cava inferior diameter change end of each 500cc urination	Maximum 3 hours

Secondary Outcome Measures

Name	Time	Method
Vena cava inferior diameter change with classic treatment at each hour	Maximum 3 hours

Trial Locations

Locations (1)

Adnan Yamanoğlu; 🇹🇷 Istanbul, Turkey